Baxter(US:BAX) Globenewswire·2025-11-06 13:55Core Viewpoint - A shareholder has filed a securities class action lawsuit against Baxter International Inc. for misrepresentations regarding the safety of its Novum IQ Large Volume Pump, which allegedly concealed systemic issues that could endanger patients [1][3]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who purchased Baxter common stock between February 23, 2022, and July 30, 2025 [1]. - The defendants are accused of misrepresenting the safety of the Novum IQ Large Volume Pump, which is used for intravenous fluid delivery, while hiding serious risks associated with the device [3]. Group 2: Legal Participation - Investors wishing to serve as lead plaintiffs must file necessary documents by December 15, 2025, although participation as a class member does not require serving as a lead plaintiff [4]. - All legal representation in this case is on a contingency fee basis, meaning shareholders will not incur fees or expenses [4]. Group 3: Law Firm Background - Bernstein Liebhard LLP has recovered over $3.5 billion for clients since 1993 and has represented large public and private pension funds [5]. - The firm has been recognized multiple times for its success in litigating class actions, being named to The National Law Journal's "Plaintiffs' Hot List" and listed in The Legal 500 for sixteen consecutive years [5].